Takuma Onoe

Randomized Phase II Trial Comparing Site-Specific Treatment Based on Gene Expression Profiling With Carboplatin and Paclitaxel for Patients With Cancer of Unknown Primary Site

Hidetoshi Hayashi, Takayasu Kurata, Yuichi Takiguchi et al. · Journal of Clinical Oncology · 2019 · 166 citations

Phase II trial of combination treatment with paclitaxel, carboplatin and cetuximab (PCE) as first-line treatment in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CSPOR-HN02)

Makoto Tahara, Naomi Kiyota, Tomoya Yokota et al. · Annals of Oncology · 2018 · 92 citations · Full text

4-step 4-h carboplatin desensitization protocol for patients with gynecological malignancies showing platinum hypersensitivity: a retrospective study

Naoto Takase, Koji Matsumoto, Takuma Onoe et al. · International Journal of Clinical Oncology · 2014 · 29 citations

Retrospective Study, Platinum Hypersensitivity, Medicine +7

Phase II trial of combination treatment with paclitaxel, carboplatin and cetuximab (PCE) as first-line treatment in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CSPOR-HN02).

Makoto Tahara, Naomi Kiyota, Tomoya Yokota et al. · Journal of Clinical Oncology · 2016 · 27 citations

Neoadjuvant Therapy, Pathology, First-line Treatment +16

Phase 1 dose‐escalation study of single‐agent veliparib in Japanese patients with advanced solid tumors

Tadaaki Nishikawa, Koji Matsumoto, Kenji Tamura et al. · Cancer Science · 2017 · 24 citations · Full text

Neuro-oncology, Dose‐escalation Study, Medicine +15